Perpetual Medicines Raises $8M in Seed Round for Peptide Drug Discovery Platform

Perpetual Medicines  announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for pe...

December 04, 2023 | Monday | News
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, O...

December 04, 2023 | Monday | News
Route 92 Medical Secures $31M in Series F Funding to Boost Expansion in Growing Stroke Treatment Market

The oversubscribed capital raise was led by existing venture capital investors: U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and...

November 17, 2023 | Friday | News
T-Therapeutics Secures £48M in Series A for Advancing Next-Gen TCR Therapeutics in Cancer Treatment Transformation.

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofin...

November 16, 2023 | Thursday | News
Inari Medical Closes Acquisition of LimFlow

“The close of the LimFlow acquisition allows us to begin to integrate this exciting technology that is offering new hope to patients suffering from C...

November 16, 2023 | Thursday | News
£14.5 Million Funding Boost for Neurodegenerative Research Projects in the UK

Seven major research projects to receive more than £14 million to develop new tests, treatments and devices for neurodegenerative diseases includin...

November 14, 2023 | Tuesday | News
Gero Secures $6M to Unlock Aging's Secrets with Physics-Powered GenAI Biotech"

Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to con...

October 19, 2023 | Thursday | News
Novo Nordisk raises sales and operating profit outlook for 2023

In the first nine months of 2023, Novo Nordisk’s sales increased by 33% and operating profit increased by 37% both at CER. Profit and loss (CE...

October 16, 2023 | Monday | News
AstraZeneca Supports Eight New Scientist Projects in R&D Postdoc Challenge

AstraZeneca  announced the eight winners of the 2023 R&D Postdoctoral Challenge. and agreed to fund them to hold a postdoctoral position in one of...

October 13, 2023 | Friday | News
GE Healthcare Inks $44M Deal with BARDA for AI-Enhanced Ultrasound Tech to Boost Trauma Care and Disaster Preparedness

GE HealthCare (Nasdaq: GEHC) today announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA)&mdash...

October 13, 2023 | Friday | News
Astrazeneca Foundation Awards 12 Nonprofit Organizations More Than $2M to Advance Health Equity

AstraZeneca Foundation celebrates its 30th anniversary, the organization has awarded 12 nonprofit organizations $2,170,318 in grants across eight US states...

October 11, 2023 | Wednesday | News
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...

October 06, 2023 | Friday | News
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools

Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of mu...

October 05, 2023 | Thursday | News
MediciNova Receives Gene Therapy Milestone Payment

The milestone payment of $1 million is the result of the successful achievement of a clinical development milestone for a gene therapy product based o...

October 05, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close